• 1. Enabling shape memory and healable effects in a conjugated polymer by incorporating siloxane via dynamic imine bond?
  Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
• 2. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?
  Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198

Introduction to tert-butyl 2-(2-hydroxy-5-methylcyclohexyl)piperidine-1-carboxylate (CAS No. 1559429-30-9)

tert-butyl 2-(2-hydroxy-5-methylcyclohexyl)piperidine-1-carboxylate (CAS No. 1559429-30-9) is a complex organic compound that has garnered significant attention in recent years due to its potential applications in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a tert-butyl group, a piperidine ring, and a hydroxymethylcyclohexyl moiety. These structural elements contribute to its diverse chemical properties and biological activities.

The chemical structure of tert-butyl 2-(2-hydroxy-5-methylcyclohexyl)piperidine-1-carboxylate is of particular interest due to its potential as a building block for the synthesis of more complex molecules. The tert-butyl group provides steric protection, while the piperidine ring and hydroxymethylcyclohexyl moiety offer functional groups that can be readily modified through various chemical reactions. This versatility makes it an attractive candidate for the development of novel drugs and therapeutic agents.

In the context of medicinal chemistry, tert-butyl 2-(2-hydroxy-5-methylcyclohexyl)piperidine-1-carboxylate has been explored for its potential as a prodrug or as an intermediate in the synthesis of bioactive compounds. Prodrugs are inactive precursors that are converted into active drugs within the body, often improving pharmacokinetic properties such as solubility, stability, and bioavailability. The presence of the hydroxymethylcyclohexyl moiety in this compound suggests that it could be metabolized to release active metabolites with therapeutic effects.

Recent studies have highlighted the importance of piperidine-containing compounds in the development of drugs targeting various diseases. For instance, piperidine derivatives have shown promise in the treatment of neurological disorders, cardiovascular diseases, and cancer. The specific structure of tert-butyl 2-(2-hydroxy-5-methylcyclohexyl)piperidine-1-carboxylate may offer unique advantages in terms of binding affinity and selectivity for specific biological targets, making it a valuable candidate for further investigation.

The synthesis of tert-butyl 2-(2-hydroxy-5-methylcyclohexyl)piperidine-1-carboxylate typically involves multi-step reactions, including the formation of the piperidine ring and the introduction of the hydroxymethylcyclohexyl moiety. Advanced synthetic methods, such as transition-metal-catalyzed reactions and asymmetric synthesis techniques, have been employed to achieve high yields and enantioselectivity. These methods not only enhance the efficiency of the synthesis but also ensure that the final product meets stringent purity standards required for pharmaceutical applications.

In addition to its potential as a drug candidate, tert-butyl 2-(2-hydroxy-5-methylcyclohexyl)piperidine-1-carboxylate has been studied for its role in biological systems. Research has shown that compounds with similar structures can modulate various signaling pathways involved in cellular processes such as inflammation, apoptosis, and cell proliferation. Understanding these interactions can provide insights into the mechanisms underlying disease progression and inform the design of more effective therapeutic strategies.

The physicochemical properties of tert-butyl 2-(2-hydroxy-5-methylcyclohexyl)piperidine-1-carboxylate, including its solubility, stability, and partition coefficient (logP), are crucial for its application in drug development. These properties can be optimized through structural modifications to enhance drug delivery and reduce side effects. For example, increasing solubility can improve oral bioavailability, while reducing logP can enhance permeability across biological membranes.

Clinical trials involving compounds derived from tert-butyl 2-(2-hydroxy-5-methylcyclohexyl)piperidine-1-carboxylate have shown promising results in preclinical studies. These trials have focused on evaluating the safety and efficacy of these compounds in animal models of various diseases. Preliminary data suggest that these compounds exhibit favorable pharmacokinetic profiles and demonstrate significant therapeutic effects without causing severe adverse reactions.

The future prospects for tert-butyl 2-(2-hydroxy-5-methylcyclohexyl)piperidine-1-carboxylate are promising. Ongoing research aims to further elucidate its biological activities and optimize its chemical structure for improved therapeutic outcomes. Collaborative efforts between chemists, biologists, and clinicians are essential to translate these findings into practical applications that benefit patients.

In conclusion, tert-butyl 2-(2-hydroxy-5-methylcyclohexyl)piperidine-1-carboxylate (CAS No. 1559429-30-9) represents a promising compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique structural features and versatile chemical properties make it an attractive candidate for the development of novel drugs targeting a wide range of diseases. Continued research and development will undoubtedly uncover new applications and enhance our understanding of this fascinating compound.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)